Private company
Lincoln Park Capital Fund, LLC
American company, incorporated in Illinois. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersIL1
Corporate structure
Lincoln Park Capital Fund, LLC sits at the top of its group. 10 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Lincoln Park Capital Fund, LLC IL
- Cellectar Biosciences, Inc. Stake · Madison, Wisconsin, United States
- Decoy Therapeutics Inc. Stake · Houston, Texas
- Ensysce Biosciences Stake · La Jolla, California
- GRI Bio, Inc. Stake · La Jolla, California
- KIORA PHARMACEUTICALS INC Stake · Waltham, Massachusetts, United States
- Nabriva Therapeutics plc Stake · L2
- Tracon Pharmaceuticals, Inc. Stake · San Diego, California
- WINDTREE THERAPEUTICS INC /DE/ Stake · Warrington, Pennsylvania
- X4 Pharmaceuticals, Inc Stake · Cambridge, Massachusetts, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (9 companies). Each entity in the chart links to its source.
Stakes it holds
Lincoln Park Capital Fund, LLC has told the SEC it owns more than 5% of 9 companies, latest first (Schedules 13D and 13G).
- Cellectar Biosciences, Inc.SC 13G/A Oct 25, 2022 to Feb 14, 20242
- Ensysce BiosciencesSC 13G/A Feb 7, 2023 to Feb 14, 20243
- KIORA PHARMACEUTICALS INCSC 13G/A Jul 28, 2022 to Feb 14, 20244
- Tracon Pharmaceuticals, Inc.SC 13G/A Jun 2, 2023 to Feb 14, 20245
- WINDTREE THERAPEUTICS INC /DE/SC 13G/A Apr 24, 2023 to Feb 14, 20246
- X4 Pharmaceuticals, IncSC 13G/A Jan 19, 2022 to Feb 14, 20247
- GRI Bio, Inc.SC 13G May 18, 20228
- Decoy Therapeutics Inc.SC 13G Apr 27, 20229
- Nabriva Therapeutics plcSC 13G Nov 19, 202110
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10